Jan Biotech, Inc.

Jan Biotech, Inc's intellectual properties include novel molecular in vitro assays for clinical diagnosis and quantification of latent infections such as HIV-1, as well as detection of aggressive cancer (ex., prostate) and cancer treatment monitoring.